SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-19-023473
Filing Date
2019-12-31
Accepted
2019-12-31 06:01:52
Documents
1
Period of Report
2019-02-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 11160
  Complete submission text file 0001140361-19-023473.txt   12730
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Issuer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SITE B 7 OSER AVE. HAUPPAUGE NY 11788
Business Address SITE B 7 OSER AVE. HAUPPAUGE NY 11788 631-231-3233
InvaGen Pharmaceuticals, Inc. (Reporting) CIK: 0001759453 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 0331
Type: 3 | Act: 34 | File No.: 001-38114 | Film No.: 191317910